GW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November
Nov 22, 2016 13:00 pm UTC| Business
LONDON, Nov. 22, 2016 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
Nov 22, 2016 13:00 pm UTC| Business
ATHLONE, Ireland, Nov. 22, 2016 -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical needs, today announced...
Fate Therapeutics Announces Private Financing
Nov 22, 2016 13:00 pm UTC| Business
SAN DIEGO, Nov. 22, 2016 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that it...
Nov 22, 2016 13:00 pm UTC| Business
DENVER, Nov. 22, 2016 -- The WhiteWave Foods Company (NYSE:WWAV) (the “Company”) announced today that holders of a majority in aggregate principal amount of its outstanding $500,000,000 5.375% Senior Notes due 2022 (the...
CRISPR Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016 13:00 pm UTC| Business
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2016 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today...
Aclaris Therapeutics to Attend Upcoming Investor Conferences
Nov 22, 2016 13:00 pm UTC| Business
MALVERN, Pa., Nov. 22, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that management will host investor meetings during: Citi’s 2016 Global...
Cara Therapeutics to Webcast Presentation at the 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016 13:00 pm UTC| Business
STAMFORD, Conn., Nov. 22, 2016 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...